BIVALIRUDIN

作品数：20被引量：56H指数：4
导出分析报告
相关领域：医药卫生更多>>
相关作者：张亚臣相银唐勇更多>>
相关机构：上海交通大学医学院附属新华医院青岛科技大学南京工业大学更多>>
相关期刊：《Chinese Medical Journal》《World Journal of Cardiology》《Cardiovascular Innovations and Applications》《现代化工》更多>>
相关基金：国家自然科学基金中国博士后科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=South China Journal of Cardiologyx
共 条 记 录，以下是1-6
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Effects of bivalirudin on acute myocardial infarction in patients undergoing emergency percutaneous coronary intervention被引量：3
《South China Journal of Cardiology》2018年第4期237-243,共7页SUN Xue-yu ZHANG Yu-ying HAN Zeng-lei 
supported by Qingdao Municipal Health Commission Planning Project(No.2015-WJZD066)
Background It.s an effective treatment to implement percutaneous coronary intervention in acute myocardial infarction patients,which rapidly achieve coronary reperfusion. However,many patients with no-reflow,leading t...
关键词：acute myocardial infarction ANGIOPLASTY NO-REFLOW BIVALIRUDIN 
Effect of bivalirudin on coagulation function and prognosis in patients with coronary artery disease and renal insufficiency undergoing PCI
《South China Journal of Cardiology》2016年第3期147-152,共6页韩兆帅 纪阳 刘松 文明洪 
Background Renal insufficiency is associated with an excess risk of vascular complications and bleeding events in patients who undergo PCI. Heparin is still used commonly for PCI, but the bleeding complications is hig...
关键词：BIVALIRUDIN coronary artery disease renal insufficiency coagulation function percutaneous coronary intervention 
Bivalirudin versus heparin with or without glycoprotein Ⅱb/Ⅲa inhibitors in?patients with STEMI undergoing primary percutaneous coronary intervention:Pooled patient-level analysis from the
《South China Journal of Cardiology》2014年第4期290-295,共6页
In the HORIZONS-AMI （Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction） trial, 3,602 patients undergoing primary percutaneous coronary intervention （PCI） for ST-segment elevatio...
关键词：STEMI PCI Bivalirudin versus heparin with or without glycoprotein a inhibitors in?patients with STEMI undergoing primary percutaneous coronary intervention 
Bivalirudin is superior to heparins alone with bailout GP Ⅱb / Ⅲa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX tria被引量：21
《South China Journal of Cardiology》2014年第3期223-226,共4页
Aims In the HORIZONS trial, in-hospital treatment with bivalirudin reduced bleeding and mortality in primary percutaneous coronary intervention（PCI） compared with heparin and routine glycoprotein Ⅱb / Ⅲa inhibitor...
关键词：heparin alone elevation routine stent bleeding restricted receiving specified glycoprotein 
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction
《South China Journal of Cardiology》2011年第4期268-268,共1页
Background The combination of glycoprotein Ⅱb/Ⅲ a inhibitors and heparin has not been compared with bivalirudin in studies specifically involving patients with non-ST-segment elevation myocardial infarction undergoi...
关键词：ST Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction PCI 
Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention results from a propensity score-matched analysis of the evaluation of drug-eluting stents and ischemic events (EVENT) registry被引量：1
《South China Journal of Cardiology》2011年第4期271-272,共2页
Background Prior randomized trials have shown reduced bleeding with bivalirudin compared with unfractionated heparin （UFH） in patients undergoing percutaneous coronary intervention （PCI）. However, it is not known ...
关键词：UFH Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention results from a propensity score-matched analysis of the evaluation of drug-eluting stents and ischemic events EVENT REGISTRY 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部